Skip to main content

Advertisement

SpringerLink
Log in

Do Over-the-counter medications for migraine hinder the physician?

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The availability of many over-the-counter drugs that were formerly prescription medications enable patients with migraine to self-medicate easily and delay entry into the appropriate medical management. The potential for adverse effects, drug interactions, and analgesic rebound headaches can often be complications that hinder treatment. Over-the-counter products force the patient to employ a less effective step-care approach as opposed to evidence-based guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache: an evidence-based review. Neurology 2000, 55:754–762. Utilizes an evidence-based consensus review to make recommendations for migraine diagnosis and management.

    PubMed  CAS  Google Scholar 

  2. Silberstein SD, Lipton RB, Dalessio DJ: Wolff’s Headache and Other Head Pain. Edited by Silberstein SD, Lipton RB, Dalessio DJ. New York: Oxford University Press; 200l.

    Google Scholar 

  3. Bajwa ZH, Sabahat A: Pathophysiology, clinical manifestations, and diagnosis of migraine headache. Available at http:/ /www.uptodateonline.com. Accessed November 25, 2001.

  4. Aurora SK: Pathophysiology of migraine headache. Pain Headache 2001, 5:179–182.

    CAS  Google Scholar 

  5. Goadsby PJ: Current concepts of the pathophysiology of migraine. In Neurologic Clinics. Edited by Mathew NT. Philadelphia: WB Saunders; 1997, 15:27–44.

    Google Scholar 

  6. Goadsby PJ: Pathophysiology of headache. In Wolff’s Headache and Other Head Pain. Edited by Silberstein SD, Lipton RB, Dalessio DJ. New York: Oxford University Press; 2001:57–72.

    Google Scholar 

  7. Lipton RB, Diamond S, Reed M, et al.: Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001, 41:638–645. Identifies results of two large epidemiologic migraine surveys in the US population, including trends of diagnosis and treatment.

    Article  PubMed  CAS  Google Scholar 

  8. Sheftell FD: Role and impact of over-the-counter medications in the management of headache. In Neurologic Clinics. Edited by Mathew NT. Philadelphia: WB Saunders; 1997, 15:187–198.

    Google Scholar 

  9. Matcher DB, Young WB, Rosenberg JH, et al.: Evidence-based guidelines for migraine headache in the primary care setting: pharmacologic management of acute attacks. The US Headache Consortium. 2000. Available at http:/www.aan.com. In depth review of acute therapy recommendations for migraine management.

  10. Lipton RB, Baggish JS, Stewart WF, Codispoti JR: Efficacy and safety of acetaminophen in the treatment of migraine. Arch Intern Med 2000, 160:3486–3492.

    Article  PubMed  CAS  Google Scholar 

  11. Catella-Lawson F, Reilly MP, Kapoor SC, et al.: Cyclooxygenase inhibitors and the antiplatelet effects or aspirin. N Engl J Med 2001, 345:1809–1817.

    Article  PubMed  CAS  Google Scholar 

  12. Saper JR: Drug overuse among patients with headache. In Neurologic Clinics. Edited by Packard RC. Philadelphia: WB Saunders; 1983:1:465–477.

    Google Scholar 

  13. Pittler MH, Vogler BK, Ernst E: Feverfew for preventing migraine. Cochrane Database Syst Rev 2001, 2:1–10.

    Google Scholar 

  14. Palevitch D, Earon G, Carusso RL: Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine. Phytother Res 1997, 11:508–511.

    Article  Google Scholar 

  15. Johnson ES, Kadam NP, Hylands DM, Hylands JP: Efficacy of feverfew as prophylactic treatment of migraine. Br Med J 1985, 291(6495):569–673.

    Article  CAS  Google Scholar 

  16. Murphy JJ, Heptinstall S, Mitchell JR: Randomized doubleblind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988, 2(8604):189–192.

    Article  PubMed  CAS  Google Scholar 

  17. deWeerdt CJ, Tootsma HP, Hendriks H: Herbal medicines in migraine prevention: randomized double-blind placebocontrolled crossover trial of feverfew preparation. Phytomedicine 1996, 3:225–230.

    Google Scholar 

  18. Micromedex R Healthcare Series: MICROMEDEX, Greenwood Village, Colorado (Edition expires March 3, 2002).

  19. Mauskop A: Alternative therapies in headache: is there a role? Med Clin North Am 2001, 85(4):1077–1084.

    Article  PubMed  CAS  Google Scholar 

  20. Silberstein S, Lipton R, Goadsby P: Chronic daily headache: diagnosis and treatment. In Headache in Clinical Practice. Edited by Silberstein S, Lipton R, Goadsby P. Oxford: Isis Medical Media Ltd; 1998:101–114. Discusses medication misuse in relationship to appropriate identification and treatment of rebound headaches and contributions to chronic daily headache.

    Google Scholar 

  21. Matthew NT: Transformed migraine, analgesic rebound, and other chronic daily headaches. In Neurologic Clinics. Edited by Matthew NT. Philadelphia: WB Saunders; 1997, 15:167–186.

    Google Scholar 

  22. Warner JS: The outcome of treating patients with suspected rebound headache. Headache 2001, 41:685–692.

    Article  PubMed  CAS  Google Scholar 

  23. Sanchez del Rio M, Silberstein S: How to pick optimal acute treatment for migraine headache. Pain Headache 2001, 5:170–178.

    CAS  Google Scholar 

  24. Hu XH, Markson LE, Lipton RB, et al.: Burden of migraine in the United States: disability and economic costs. Arch Inter Med 1999, 159:813–818.

    Article  CAS  Google Scholar 

  25. Lipton RB, Stewart WF, Von Korff M: The burden of migraine: a review of cost to society. Pharmacoeconomics 1994, 3:215–221.

    Google Scholar 

  26. Schweitzer SO: The economics of migraine. Am J Manag Care 1999, 5(Suppl 2):S91-S98.

    Google Scholar 

  27. Rapoport AM, Adelman JU: Cost of migraine management: a pharmacoeconomic overview. Am J Manag Care 1998, 4:531–545.

    PubMed  CAS  Google Scholar 

  28. Legg RF, Sclar DA, Nemec NL, et al.: Cost-effectiveness of sumatriptan in a managed care population. Am J Manag Care 1997, 3:117–122.

    PubMed  CAS  Google Scholar 

  29. Solomon GD, Cady RK, Klapper JA, et al., on behalf of the 042 Clinical Trial Study Group: Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology 1997, 49:1219–1225.

    PubMed  CAS  Google Scholar 

  30. Adelman JU, Sharfman M, Johnson R, et al.: Impact of oral sumatriptan in workplace productivity, health-related quality of life, healthcare use, and patient satisfaction with medication in nurses with migraine. Am J Manag Care 1996, 2:1407–1416.

    Google Scholar 

  31. Cady RC, Ryan R, Jhingran P, et al.: Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998, 158:1013–1018.

    Article  PubMed  CAS  Google Scholar 

  32. Lofland JH, Johnson NE, Batenhorst AS, Nash DB: Changes in resource use and outcomes for patients with migraine treated with sumatariptan: a managed care perspective. Arch Intern Med 1999, 159:857–863.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of Mississippi Medical Center, 2500 North State Street, 39216, Jackson, MS, USA

    Thais Brown Tonore MD, Deborah S. King PharmD & Sara L. Noble PharmD

Authors
  1. Thais Brown Tonore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah S. King PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sara L. Noble PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonore, T.B., King, D.S. & Noble, S.L. Do Over-the-counter medications for migraine hinder the physician?. Current Science Inc 6, 162–167 (2002). https://doi.org/10.1007/s11916-002-0014-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-002-0014-9

Keywords

Search

Navigation